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Ever since attention has been called to the French paradox (eg,
the lower mortality rate for ischemic heart disease in France despite
the high intake in saturated fat), there has been speculation that
alcohol consumption may play a protective role in this epidemio-
logic observation.1 Some of the protective effects of alcohol, and
especially red wine, are thought to include inhibition of low-
density lipoprotein oxidation, increased high-density lipoprotein,
inhibition of smooth muscle cell proliferation, inhibition of plate-
let aggregation, and vasorelaxation.2 It is not currently known
whether the protective effects of red wine are due to the alcohol or
to the complex polyphenols that are contained within it.2
Interestingly, people who drink no alcohol have increased
mortality compared with those people who drink a small amount,
leading to the description of a “J-curve” in mortality.3 It is the
reduced mortality associated with moderate alcohol consumption
(10 to 20 U/wk), the inflection point on the J-curve, that theonsistent with the reported literature; patients undergoing femo-
al endarterectomy who drank no alcohol had increased mortality
nd worse plaque morphology compared with drinkers. However,
here was decreased mortality in patients with higher amounts of
lcohol consumption.
This controversial study raises more questions than it answers:
● Why was the J-curve only partially detected in patients under-
going femoral endarterectomy?
● Does the authors’ assignment of the category of 1 to 10
U/wk reflect the inflection point of the J-curve in this patient
population?
● Does a wider range of alcohol consumption, especially 10 to
20 U/wk compared with lower and higher amounts, need to
be examined?● Why did the authors fail to find a similar effect in patients
undergoing carotid endarterectomy?
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the effects of alcohol, the confounding effects of diet and/or
genetics, or possibly of the design of the study?
● Can studies that self-report alcohol use be reliable?
● Can these European studies be replicated elsewhere?
This study also raises the question whether in patients who
develop advanced plaques requiring surgical removal, does alco-
hol, wine, or diet play a role in plaque composition, as they do at
earlier stages of plaque development?
The association of alcohol consumption with femoral plaque
composition and cardiovascular events, if replicated by other stud-
ies, suggests that additional research is needed to clarify the bio-ogic and molecular mechanisms of alcohol’s effects on the vascu-
ature, with special attention to confounding effects both in the
ine as well as in the study population.
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